Farmax India Limited announced unaudited standalone and consolidated earnings results for the third quarter and first nine months ended December 31, 2016. For the quarter, on standalone basis, the company announced net income from operations of INR 1.088 million compared to INR 41.388 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 8.060 million compared to INR 50.587 million a year ago. Loss from ordinary activities before tax was INR 8.060 million compared to INR 50.587 million a year ago. Net loss was INR 8.060 million or INR 0.02 per basic and diluted share for before and after extraordinary items compared to INR 50.587 million or INR 0.09 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, on standalone basis, the company announced net income from operations of INR 42.854 million compared to INR 146.913 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 24.895 million compared to INR 92.026 million a year ago. Loss from ordinary activities before tax was INR 24.464 million compared to INR 92.026 million a year ago. Net loss was INR 24.464 million or INR 0.05 per basic and diluted share for before and after extraordinary items compared to INR 92.026 million or INR 0.08 per basic and diluted share for before and after extraordinary items a year ago. For the quarter, on consolidated basis, the company announced net income from operations of INR 1.088 million compared to INR 41.388 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 8.060 million compared to INR 50.587 million a year ago. Loss from ordinary activities before tax was INR 8.060 million compared to INR 50.587 million a year ago. Net loss was INR 8.060 million or INR 0.02 per basic and diluted share for before and after extraordinary items compared to INR 50.587 million or INR 0.09 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, on consolidated basis, the company announced net income from operations of INR 42.854 million compared to INR 146.913 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 24.895 million compared to INR 92.026 million a year ago. Loss from ordinary activities before tax was INR 24.895 million compared to INR 92.026 million a year ago. Net loss was INR 24.895 million or INR 0.05 per basic and diluted share for before and after extraordinary items compared to INR 92.026 million or INR 0.08 per basic and diluted share for before and after extraordinary items a year ago.